{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:11:11Z","timestamp":1761430271908,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1080\/146532402317381875","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:38:19Z","timestamp":1027687099000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells"],"prefix":"10.1016","volume":"4","author":[{"given":"P.","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Story","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mrozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/146532402317381875_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versusleukaemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1080\/146532402317381875_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","article-title":"Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen","volume":"88","author":"Cardoso","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1080\/146532402317381875_bib3","first-page":"596a","article-title":"AML-derived immunomodulatory factor(s) inhibit T cell cytokine secretion and proliferation via inhibition of NF-ATc activation and failure to upregulate c-MYC (Abstract)","volume":"94","author":"Buggins","year":"1999","journal-title":"Blood"},{"key":"10.1080\/146532402317381875_bib4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/hum.1997.8.11-1375","article-title":"Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemia cells","volume":"8","author":"Hirano","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1080\/146532402317381875_bib5","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood.V92.5.1677","article-title":"CD80- transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens","volume":"92","author":"Mutis","year":"1998","journal-title":"Blood"},{"key":"10.1080\/146532402317381875_bib6","first-page":"465","article-title":"Reversal of tolerance to human MUCI antigen in MUCI transgenic mice immunised with fusions of dendritic and carcinoma cells","volume":"184","author":"Gong","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/146532402317381875_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/stem.150094","article-title":"Bone marrowderived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines","volume":"15","author":"Mayordomo","year":"1997","journal-title":"Stem Cells"},{"key":"10.1080\/146532402317381875_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.med.50.1.507","article-title":"Dendritic cell vaccines for cancer immunotherapy","volume":"50","author":"Timmerman","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1080\/146532402317381875_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1615\/CritRevImmunol.v18.i1-2.130","article-title":"Human leukaemiaderived dendritic cells: ex vivo development of specific antileukemic cytotoxicity","volume":"18","author":"Choudhury","year":"1998","journal-title":"Crit Rev Immunol"},{"key":"10.1080\/146532402317381875_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0198-8859(96)00285-6","article-title":"Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia percursor cells","volume":"53","author":"Smit","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1080\/146532402317381875_bib11","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO;2-S","article-title":"Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias","volume":"29","author":"Charbonnier","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1080\/146532402317381875_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.leu.2402013","article-title":"Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemiaspecific cytotoxic T cell response from patients with acute myeloid leukemia","volume":"15","author":"Woiciechowshy","year":"2001","journal-title":"Leukemia"},{"key":"10.1080\/146532402317381875_bib13","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1182\/blood.V75.11.2097.2097","article-title":"Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia","volume":"75","author":"Touw","year":"1990","journal-title":"Blood"},{"key":"10.1080\/146532402317381875_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jcp.45.5.420","article-title":"Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction","volume":"45","author":"Wan","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.1080\/146532402317381875_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.leu.2400542","article-title":"The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia","volume":"11","author":"Sykes","year":"1997","journal-title":"Leukemia"},{"key":"10.1080\/146532402317381875_bib16","first-page":"247","article-title":"Immunosuppressive factors in human cancer","volume":"60","author":"Sulitzeanu","year":"1993","journal-title":"Adv Cancer Res"},{"key":"10.1080\/146532402317381875_bib17","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V94.10.3531.422k14_3531_3540","article-title":"Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies","volume":"10","author":"Cardoso","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1080\/146532402317381875_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0952-7915(00)00147-3","article-title":"Co-stimulatory wars: the tumor menace","volume":"12","author":"Hurwitz","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1080\/146532402317381875_bib19","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.154.6.2612","article-title":"Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation","volume":"154","author":"Hintzen","year":"1995","journal-title":"J Immunol"},{"key":"10.1080\/146532402317381875_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.186.1.65","article-title":"Induction of a CD8 cytotoxic T lymphocyte response by cross priming requires cognate CD4 help","volume":"186","author":"Bennett","year":"1997","journal-title":"J Exp Med"},{"key":"10.1080\/146532402317381875_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for inducing cytotoxic T cell response by cross-priming is mediated via CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"10.1080\/146532402317381875_bib22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T cell help for cytotoxic T Lymphocytes is mediated by CD40- CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1080\/146532402317381875_bib23","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1128\/JVI.72.9.7440-7449.1998","article-title":"CD40 ligand-mediated interactions are involved in the generation of memory CD8+ cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection","volume":"72","author":"Borrow","year":"1998","journal-title":"J Virol"},{"key":"10.1080\/146532402317381875_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.188.2.297","article-title":"CD4 T cell cytokine differentiation: The B cell activation molecule OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor Blr-1","volume":"188","author":"Flynn","year":"1998","journal-title":"J Exp Med"},{"key":"10.1080\/146532402317381875_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.191.2.365","article-title":"Impairment of antigenpresenting cell function in mice lacking expression of OX40 ligand","volume":"191","author":"Murata","year":"2000","journal-title":"J Exp Med"},{"key":"10.1080\/146532402317381875_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses","volume":"186","author":"Shuford","year":"1997","journal-title":"J Exp Med"},{"key":"10.1080\/146532402317381875_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1999","journal-title":"Nat Med"},{"key":"10.1080\/146532402317381875_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2141.1999.01474.x","article-title":"Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells","volume":"106","author":"Schmitter","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1080\/146532402317381875_bib29","first-page":"163","article-title":"Douin-EchinardVet al Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells","volume":"5","author":"CoudercB","year":"1998","journal-title":"Cancer Gene Ther"},{"key":"10.1080\/146532402317381875_bib30","series-title":"Dendritic cells in fundamental and clinical immunology","first-page":"371","article-title":"Activation of primary allogeneic CD8+ T cells by dendritic cells generated in vitro from CD34+ cord blood progenitor cells","author":"Wettendorff","year":"1995"},{"key":"10.1080\/146532402317381875_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1080\/146532402317381875_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.164.2.562","article-title":"Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen","volume":"164","author":"Surman","year":"2000","journal-title":"J Immunol"},{"key":"10.1080\/146532402317381875_bib33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.283.5405.1183","article-title":"Reciprocal control of T helper cell and dendritic cell differentiation","volume":"283","author":"Rissoan","year":"1999","journal-title":"Science"},{"key":"10.1080\/146532402317381875_bib34","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1080\/146532402317381875_bib35","first-page":"70a","article-title":"Effect of leukemic cell microenvironment on the differentiation of dendritic cells from normal monocytes: Phenotypic and functional analysis [Abstract]","volume":"94","author":"Rigolin","year":"1999","journal-title":"Blood"},{"key":"10.1080\/146532402317381875_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.0.CO;2-6","article-title":"Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats","volume":"72","author":"Chaux","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1080\/146532402317381875_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/00313029309090853","article-title":"S100 positive dendritic cells in human lung tumours associated with cell differentiation and enhanced survival","volume":"25","author":"Zeid","year":"1993","journal-title":"Pathology"},{"key":"10.1080\/146532402317381875_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archotol.1991.01870210079015","article-title":"Langerhans cells related to progress in patients with laryngeal carcinoma","volume":"117","author":"Gallo","year":"1991","journal-title":"Arch Otorhinolaryngol Head Neck Sug"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324902710517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324902710517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:08:16Z","timestamp":1761430096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324902710517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S1465324902710517"],"URL":"https:\/\/doi.org\/10.1080\/146532402317381875","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/146532402317381875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}